Wilson’s disease is an autosomal recessive condition characterized by the accumulation of copper in the liver, brain, and cornea. Patients may exhibit a variety of symptoms, including jaundice, abdominal pain, seizures, dysarthria, dystonia, and the presence of a brownish ring around the iris.

It has a prevalence of 1 in every 30,000 individuals and is equally prevalent in males and females. Copper chelation therapy using penicillamine and trientine is the primary treatment for this condition.